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Abstract
We analyzed data from the Global Adult Tobacco Survey (GATS)
from 21 countries to categorize smokers by stages of cessation and
highlight interventions that could be tailored to each stage. GATS
is a nationally representative household survey that measures to-
bacco use and other key indicators by using a standardized pro-
tocol. The distribution of smokers into precontemplation, contem-
plation, and preparation stages varied by country. Using the stages
of change model, each country can design and implement effect-
ive interventions suitable to its cultural, social, and economic situ-
ations to help smokers advance successfully through the stages of
cessation.
Objective
Tobacco use is a major cause of preventable diseases. Article 14 of
the World Health Organization’s Framework Convention on To-
bacco Control (FCTC) shows countries’ interest in implementing
support for smoking cessation (1). However, to successfully im-
plement Article 14, countries should identify the stages of cessa-
tion among tobacco smokers in their populations. This research at-
tempts to identify those stages on the basis of the stages of change
model so that countries can develop stage-specific interventions to
help their smoker populations through successful cessation (2,3).
Using Global Adult Tobacco Survey (GATS) data, we applied
processes and stages of change to characterize the cessation status
of smokers in 21 countries and discuss potential cessation inter-
ventions.
Methods
GATS is a household survey of adults aged 15 years or older that
uses a standardized protocol to collect data in all  participating
countries. A multistage cluster sampling design is used in all coun-
tries to achieve nationally representative samples (4). GATS was
conducted from 2009 to 2013 in 21 countries: Argentina (2012),
Bangladesh (2009), China (2010), Egypt (2009), Greece (2013),
India (2010), Indonesia (2011), Malaysia (2011), Mexico (2009),
Nigeria  (2012),  Panama  (2013),  Philippines  (2009),  Poland
(2010), Qatar (2013), Romania (2011), Russia Federation (2009),
Thailand (2011), Turkey (2012), Ukraine (2010), Uruguay (2009),
and Vietnam (2010).
Response rates ranged from 65.1% (Poland) to 97.3% (Egypt),
totaling 57,066 adult smokers from all 21 countries. All data (for
each country) were weighted and poststratified to the national
adult population in the respective countries (4). Details of GATS
methods, including sampling design and data quality assurance,
are available elsewhere (4).
GATS measures tobacco use and other key tobacco indicators.
Current smokers were defined as adults who smoked either daily
or less than daily. We focus on the first 3 stages of change (pre-
contemplation, contemplation, and preparation), which were cal-
culated by using responses to questions on last or most recent quit
attempts in the past 12 months, duration of recent quit attempts,
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and future cessation intentions (2,5,6). The precontemplation stage
included smokers who did not make an attempt to quit in the past
12  months  and  who  did  not  consider  quitting  in  the  next  12
months. Although some studies considered only 6 months for in-
tention to quit (2,5), GATS protocol used 12 months for this beha-
vioral aspect. Contemplation included smokers who reported con-
sidering quitting within the next 12 months except for those con-
sidering quitting in the next month who had made a quit attempt of
24 hours or more in the past 12 months. The preparation stage in-
cluded smokers who are thinking of quitting smoking within the
next month and have made a quit attempt of at least 24 hours over
the past 12 months (2,5,6).
Results
Tobacco smoking prevalence among the 21 countries  (Table),
ranged from 3.9% (Nigeria) to 39.1% (Russia Federation). Across
all countries, most smokers were in the precontemplation stage,
followed by the  contemplation stage and then the  preparation
stage. On average, 74.8% of smokers were categorized as being in
the  precontemplation  stage,  ranging  from 61.4% (Qatar)  and
61.6% (Bangladesh) to 89.5% (Indonesia).
The percentage of smokers in the contemplation stage was lower
than that of smokers in the precontemplation stage. Percentages
ranged from 7.1% (Indonesia) to 31.2% (Qatar). The preparation
stage yielded the lowest percentage of smokers in all countries at
an average of 6.7%. Among the GATS countries, the percentage
of smokers in the preparation stage ranged from less than 3.0%
(China, Greece, Russia Federation, and Thailand) to 12.9% (Ni-
geria).
Discussion
Distribution of smokers in stages of change varied by country. Six
countries had more than 80% of smokers at the precontemplation
stage, 8 countries had between 70% and 80%, and 7 countries had
60%  to  69%.  This  variation  may  be  attributable  to  2  sets  of
factors: 1) environmental, social, economic, and culture condi-
tions within each country (7); and 2) intercountry variations in ad-
opting cessation interventions. For example, the 6 countries with a
high proportion of smokers in precontemplation could consider
adopting intervention strategies to target this population with spe-
cific goals to increase the awareness of the risk to self and others,
the quality of life associated with cessation, and how the power of
cessation is intrinsically motivated. Such intervention strategies
should be developed within the population’s cultural milieu so that
smokers in precontemplation will accept the messages and be mo-
tivated to consider quitting (3,6). Strategies may also include pub-
lic education activities and media campaigns to motivate smokers
at  this  stage  to  think  of  quitting  (3,6).  Similarly,  adoption  of
strategies such as the use of graphic health warnings on cigarette
packs and in conspicuous public places (eg, billboards) have in-
creased smokers’ awareness of the health risks of smoking (8).
Consciousness raising and dramatic relief strategies, combined
with recognizing the need to quit,  making the decision to quit,
learning to be a nonsmoker, and sustaining the quit attempt could
also help motivate smokers to pass from the contemplation stage
to the preparation stage (3,6,9). Thus, countries with a high pro-
portion  of  smokers  in  the  contemplation  stage,  such  as
Bangladesh, Qatar, Turkey, and Uruguay, could benefit from ad-
opting both strategies to target this group.
Despite the low proportion of smokers in the preparation stage,
countries should strategically target smokers at this stage to move
them into action. For example, Bangladesh and Nigeria, each with
more than 10% of smokers in the preparation stage, could adopt
strategies that motivate this group to take action and avoid re-
lapses into earlier stages. Processes of change strategies could in-
clude self-evaluation that allows smokers to reflect on their self-
image in relation to their behavior (2,6). Use of health care pro-
viders with brief interventions or extensive intervention could be
one strategy to help smokers reflect on their smoking behavior
(10). Additionally, communities can organize “smoker cessation
clubs,” wherein past smokers congregate and exchange their suc-
cess stories, thereby influencing people in the stages of contempla-
tion and precontemplation to move into the preparation stage.
We also found that countries with high smoking rates had high
precontemplation rates, except for Panama, which is experiencing
a decline in smoking rates but still has smokers who are having
difficulty quitting (11). Particularly evident is the decline in the
youth smoking rate from 13.2% (2002) to 4.3% (2008) (12).
Although the stages of change theory (13) has limitations, this
study is the first to apply the model to data from 21 GATS coun-
tries and provide strategies anchored in experiential processes of
the social cognitive model that help move smokers from precon-
templation  through action  stages.  Interventions  suggested  are
broad in nature with built-in flexibility for each country to design
interventions that are suitable to its culture, environment, and so-
cioeconomic situation.
Study limitations also include the use of self-reported data, which
is subject to possible recall or social desirability biases. Further-
more, differences in cessation stages across countries may reflect
not only country-specific differences but also differences in sur-
vey timing. Overall, the stages of change model provides a useful
framework for country-level cessation support,  which remains
critical to reduce tobacco use and its consequences.
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Table
Table. Weighted Estimates of Tobacco Smoking Prevalencea and Stages of Cessation, by Country, Global Adult Tobacco
Survey
Country
GATS
Country
Sample
Current Tobacco
Smokers, % (95% CI)
Sample
Size For
Stages
Precontemplation,b %
(95% CI)
Contemplation,c
% (95% CI)
Preparation,d %
(95% CI)
Argentina
2012
6,645 22.1 (19.3–25.3) 1,648 75.4 (68.4–81.2) 16.2
(12.0–21.6)
8.4 (3.8–17.8)
Bangladesh
2009
9,629 23.0 (21.9–24.2) 2,217 61.6 (57.8–65.3) 26.3
(23.5–29.3)
12.1 (10.1–14.3)
China 2010
13,354 28.1 (26.7–29.7) 4,010 83.9 (80.3–87.0) 14.0
(11.2–17.4)
2.1 (1.4–3.1)
Egypt 2009
20,946 19.4 (18.8–20.1) 4,150 72.9 (70.7–75.0) 21.0
(19.1–22.9)
6.2 (5.1–7.4)
Greece 2013
4,359 38.2 (35.7–40.8) 1,664 86.2 (82.8–89.0) 13.2
(10.5–16.4)
0.7 (0.3–1.7)
India 2010
69,296 14.0 (13.4–14.6) 11,488 74.5 (72.7–76.3) 18.6
(17.1–20.1)
6.9 (6.0–7.9)
Indonesia
2011
8,994 34.8 (33.2–36.4) 2,853 89.5 (86.7–91.8) 7.1 (5.4–9.3) 3.3 (2.4–4.6)
Malaysia 2011 4,250 23.1 (21.2–25.2) 978 85.5 (81.3–88.8) 9.3 (6.6–13.0) 5.2 (3.5–7.6)
Mexico 2009
13,627 15.9 (14.8–17.1) 1,817 64.9 (61.8–67.9) 24.1
(21.4–27.0)
11.0 (9.1–13.2)
Nigeria 2012
9,765 3.9 (3.3–4.5) 424 63.8 (56.9–70.2) 23.3
(17.8–30.0)
12.9 (8.9–18.2)
Panama 2013 16,962 6.1 (4.9–7.5) 962 79.6 (73.2–84.9) 12.1 (7.4–19.0) 8.3 (5.8–11.8)
Philippines
2009
9,705 28.2 (27.0–29.5) 2,769 79.5 (77.3–81.5) 12.3
(10.7–14.1)
8.2 (7.0–9.7)
Poland 2010
7,840 30.3 (29.0–31.7) 2,416 68.5 (65.9–70.9) 24.2
(22.0–26.5)
7.3 (6.1–8.7)
Qatar 2013
8,571 12.1 (11.1–13.1) 1,073 61.4 (56.8–65.9) 31.2
(27.2–35.5)
7.4 (5.7–9.6)
Romania 2011
5,629 26.7 (25.0–28.4) 1,053 76.5 (73.7–79.2) 18.4
(16.0–21.1)
5.1 (4.0–6.4)
Russia
Federation
2009
11,406 39.1 (37.8–40.5) 4,798 85.6 (83.7–87.4) 11.7
(10.1–13.6)
2.6 (2.1–3.4)
Thailand 2011
20,606 24.0 (22.8–25.1) 4,290 85.4 (83.4–87.2) 12.0
(10.3–13.9)
2.6 (2.0–3.5)
Abbreviation: CI, confidence interval; GATS, Global Adult Tobacco Survey.
a Tobacco smoking prevalence is the proportion of adults who currently smoke tobacco daily or less than daily.
b Precontemplation included smokers who did not make an attempt to quit in the past 12 months and were not considering quitting in the next 12
months.
c Contemplation included smokers who consider quitting within the next month to 12 months except those considering quitting within next month who
made a quit attempt of 24 hours or more in the past 12 months.
d Preparation included smokers who have made a quit attempt of 24 hours or more in the past 12 months and were considering quitting in the next
month.
e Total number of smokers in the sample.
(continued on next page)
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(continued)
Table. Weighted Estimates of Tobacco Smoking Prevalencea and Stages of Cessation, by Country, Global Adult Tobacco
Survey
Country
GATS
Country
Sample
Current Tobacco
Smokers, % (95% CI)
Sample
Size For
Stages
Precontemplation,b %
(95% CI)
Contemplation,c
% (95% CI)
Preparation,d %
(95% CI)
Turkey 2012
9,851 27.1 (25.8–28.3) 2,412 64.6 (61.8–67.3) 26.9
(24.6–29.4)
8.5 (7.2–10.0)
Ukraine 2010
8,173 28.9 (27.7–30.1) 2,392 74.1 (71.7–76.4) 20.7
(18.6–22.9)
5.3 (4.1–6.7)
Uruguay 2009
5,581 25.0 (23.3–26.6) 1,394 66.5 (63.1–69.7) 25.1
(22.2–28.3)
8.4 (6.5–10.7)
Vietnam 2010
9,925 23.8 (22.7–24.9) 2,258 70.8 (68.1–73.3) 21.6
(19.4–24.0)
7.6 (6.4–9.0)
Average 23.9 57,066e 74.8 18.5 6.7
Abbreviation: CI, confidence interval; GATS, Global Adult Tobacco Survey.
a Tobacco smoking prevalence is the proportion of adults who currently smoke tobacco daily or less than daily.
b Precontemplation included smokers who did not make an attempt to quit in the past 12 months and were not considering quitting in the next 12
months.
c Contemplation included smokers who consider quitting within the next month to 12 months except those considering quitting within next month who
made a quit attempt of 24 hours or more in the past 12 months.
d Preparation included smokers who have made a quit attempt of 24 hours or more in the past 12 months and were considering quitting in the next
month.
e Total number of smokers in the sample.
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